CN Patent

CN1281370A — 稳定的特立帕肽溶液

Assigned to Eli Lilly and Co · Expires 2001-01-24 · 25y expired

What this patent protects

描述了呈非肠道给药的溶液形式的甲状旁腺激素的稳定的药物组合物,其中治疗活性成分用缓冲液和多羟基化合物稳定。优选的制剂含有人PTH(1—34)水溶液、甘露醇、乙酸盐或酒石酸盐缓冲剂和作为防腐剂的m－甲酚或苯甲醇。

USPTO Abstract

描述了呈非肠道给药的溶液形式的甲状旁腺激素的稳定的药物组合物,其中治疗活性成分用缓冲液和多羟基化合物稳定。优选的制剂含有人PTH(1—34)水溶液、甘露醇、乙酸盐或酒石酸盐缓冲剂和作为防腐剂的m－甲酚或苯甲醇。

Drugs covered by this patent

Patent Metadata

Patent number
CN1281370A
Jurisdiction
CN
Classification
—
Expires
2001-01-24
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.